Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can stomach electricity reveal gut disease? new study investigates

NCT ID NCT06197334

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses a homemade device with electrodes placed on the belly to record electrical signals from the stomach and intestines. Researchers will compare these signals in healthy volunteers, people with Crohn's disease (with or without fibrosis), and people with functional gastrointestinal disorders. The goal is to see if the electrical patterns differ between these groups, which could eventually help diagnose or monitor gut conditions without invasive tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a non-invasive way to help diagnose or monitor gut conditions like Crohn's disease.
What could go wrong
This is a small, early-stage observational study, not a treatment trial. It may not find clear differences, and any future diagnostic use would require much more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for all participants: * Person age \> 18 years * Person has been fasting for at least 12 hours * Person who has received full information on the organization of the research and has not objected to the use of this data. * Person affiliated to or beneficiary of a social security plan * Person informed about study organization and having signed the informed consent Inclusion Criteria for healthy volunteers : * Person has no history of chronic gastro-intestinal disease * Person has no acute of gastro-intestinal disease Inclusion Criteria for Crohn's disease patients without fibrosis : * Person is already diagnosed with Crohn's disease * Person has underwent during the last 6 months : * An MRI showing no fibrosis * A blood test for C-reactive protein and fecal calprotectine * A questionnaire to asses the Harvey-Bradshaw Index Inclusion Criteria for Crohn's disease patients with fibrosis : * Person is already diagnosed with Crohn's disease * Person has underwent during the last 6 months : * An MRI showing fibrosis * A blood test for C-reactive protein and fecal calprotectine * A questionnaire to asses the Harvey-Bradshaw Index Inclusion Criteria for functional gastrointestinal disorders patients : * Person is already diagnosed with functional gastrointestinal disorders * Person has underwent an evaluation of the Rome IV criteria Exclusion Criteria for all participants: * Person having a pacemaker * Person suffering from a sensory disorder making insensitive to pain on the skin * Person suffering from a mental or motor disorders creating uncontroled movements * Person being allergic to one or more component of the device * Person being allergic to : soy, dairy food, peanuts, wheat, nuts * Person having an history of gastro-intestinal surgery * Person suffering from injury or erythema on the abdominal skin * Person having a contagious potential (bacterial, fungal or viral) * Person being in menstruation period * Person suffering from urinary incontinence * Minor (not emancipated) * Person of legal age (subject to a legal protection measure) * Adult unable to give consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohn disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Nancy

    RECRUITING

    Vandœuvre-lès-Nancy, CHRU de Nancy, 54511, France

  • CHRU de Nancy - Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.